Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity
Clinical trial NCT07594093 · RECRUITING
Trial details
- NCT number
- NCT07594093
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-29
- Primary completion
- 2027-02-22
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.